Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
Our previous study showed that proMMP-9 was activated by MMP-3 directly, and that proMMP-3 was activated by plasmin. It was postulated that the proMMP-9 activation mechanism through the protease-protease cascade existed even in vivo. The purpose of the present study was to clarify the clinical signi...
Main Authors: | Inuzuka, K, Ogata, Y, Nagase, H, Shirouzu, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
by: Ogata, Y, et al.
Published: (2001) -
TISSUE PLASMINOGEN-ACTIVATOR VERSUS UROKINASE
by: Ebers, G
Published: (1988) -
Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
by: Itoh, Y, et al.
Published: (1998) -
Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
by: Bini, A, et al.
Published: (1996) -
The crystal structure of the catalytic domain of human urokinase-type plasminogen activator.
by: Spraggon, G, et al.
Published: (1995)